Coronavirus
Coronaviruses are species of virus belonging to the family Coronaviridae. Coronaviruses are enveloped viruses with a positive-sense single-stranded RNA genome and with a nucleocapsid of helical symmetry. The genomic size of coronaviruses ranges from approximately 26 to 32 kilobases, the largest for an RNA virus. Coronaviruses primarily infect the upper respiratory and gastrointestinal tract of mammals and birds. Six different currently known strains of coronaviruses infect humans. The much-publicized human coronavirus, SARS-CoV which causes SARS, has a unique pathogenesis because it causes both upper and lower respiratory tract infections.| CAT | Product Name | Source | Product Overview | Target | Type | Datasheet | Size | Price |
|---|---|---|---|---|---|---|---|---|
| VAng-Lsx0053 | Inactivated Coronavirus Antigen | A-72 cells | Canine native Coronavirus antigen (strain 1-71). | Coronavirus | Viral Antigens |  |
1 mg | Inquiry |
| VAng-Lsx0054 | Recombinant Coronavirus Spike gp Protein (aa 1-760) [His] | Human | Coronavirus Spike glycoprotein (aa 1-760) [His], recombinant protein from human cells. | Coronavirus | Viral Antigens | |
-- | Inquiry |
| VAng-Lsx0055 | Recombinant SARS Spike Mosaic S Protein (aa 12-53, 90-115, 171-203) | Human | Recombinant SARS-CoV Spike protein containing 12-53, 90-115, 171-203 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique. | Coronavirus | Viral Antigens | |
-- | Inquiry |
| VAng-Lsx0056 | Recombinant SARS Spike Mosaic S Protein (aa 408-470, 540-573) | Human | Recombinant SARS-CoV Spike protein containing 408-470, 540-573 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique. | Coronavirus | Viral Antigens | |
-- | Inquiry |
| VAng-Lsx0057 | Recombinant SARS Spike Mosaic S Protein (aa 1051-1076, 1121-1154, 1162-1190) | Human | Recombinant SARS-CoV Spike protein containing 1051-1076, 1121-1154, 1162-1190 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique. | Coronavirus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0058 | Recombinant SARS Nucleocapsid Protein (aa 1-422) [His] | Human | SARS Nucleocapsid (aa 1-422) [His], recombinant protein from E. coli. | Coronavirus | Viral Antigens | |
-- | Inquiry |
| VAng-Lsx0059 | Recombinant SARS Matrix Protein | Human | SARS Matrix, recombinant protein from E. coli. | Coronavirus | Viral Antigens | |
-- | Inquiry |
| VAng-Lsx0060 | Recombinant SARS S Protein (aa 1-1190) [His] | Human | SARS Surface Antigen (aa 1-1190) [His], recombinant protein from HEK 293 cells. | Coronavirus | Viral Antigens | |
50 µg | Inquiry |
| VAng-Lsx0061 | Recombinant SARS S1 Protein (aa 1-667) [His] | Baculovirus | SARS S1 [His], recombinant protein from . (Accession# AAX16192.1) | Coronavirus | Viral Antigens | |
20 µg | Inquiry |
| VAng-Lsx0062 | Recombinant SARS S2 Protein [GST] | Human | SARS S2 [GST], recombinant protein from E. coli. | Coronavirus | Viral Antigens | |
500 µg | Inquiry |
| VAng-Lsx0063 | Recombinant SARS Spike Protein (aa 1-1190) [His] | Human | SARS Spike protein (aa 1-1190) [His], recombinant protein from HEK 293 cells. | Coronavirus | Viral Antigens | |
20 µg | Inquiry |
| VAng-Lsx0064 | Recombinant SARS Core Protein (aa 1-49) | Human | SARS Core Protein (aa 1-49), recombinant protein from E. coli. | Coronavirus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0065 | Recombinant SARS Core Protein (aa 340-390) | Human | SARS Core Protein (aa 340-390), recombinant protein from E. coli. | Coronavirus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0066 | Recombinant SARS E Protein (aa 1-76) | Human | SARS Envelope protein (aa 1-76), recombinant protein from E. coli. | Coronavirus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0067 | Recombinant SARS Matrix Protein (aa 182-216) | Human | SARS Matrix protein (aa 182-216), recombinant protein from E. coli. | Coronavirus | Viral Antigens | |
100 µg | Inquiry |
| VAng-Lsx0068 | Recombinant SARS ACN Protein (aa 1-49, 192-220) | Human | SARS ACN (aa 1-49, 192-220), recombinant protein from E. coli. | Coronavirus | Viral Antigens | |
-- | Inquiry |
| VAng-Lsx0069 | Recombinant SARS E Protein (aa 340-390) | Human | SARS E Antigen (aa 340-390), recombinant protein from E. coli. | Coronavirus | Viral Antigens | |
-- | Inquiry |
| VAng-Lsx0070 | Recombinant SARS E1 gp Protein (aa 182-216) | Human | SARS E1 glycoprotein (aa 182-216), recombinant protein from E. coli. | Coronavirus | Viral Antigens | |
-- | Inquiry |
| VAng-Lsx0071 | Recombinant SARS N Protein (aa 1-49) | Human | SARS N protein (aa 1-49), recombinant protein from E. coli. | Coronavirus | Viral Antigens | |
-- | Inquiry |
| VAng-Lsx0072 | Recombinant SARS Spike gp C Protein | Human | SARS Spike glycoprotein C, recombinant protein from E. coli. | Coronavirus | Viral Antigens | |
-- | Inquiry |
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
